Latest Regulatory Approval News

Rapid Critical Metals has kicked off drilling at its flagship Webbs Silver Project in New South Wales while securing additional prospective ground through a new exploration licence application, aiming to grow its district-scale silver portfolio.

Vitrafy Life Sciences has achieved a major validation milestone with US Army-backed Phase II results showing its no-wash platelet cryopreservation protocol delivers 94% post-thaw recovery, outperforming existing standards and advancing FDA registration plans.

PMET Resources has kicked off a substantial 45,000-meter drilling program at its flagship Shaakichiuwaanaan Property in Quebec, aiming to bolster lithium, caesium, and tantalum resource development ahead of updated economic studies.

Avecho Biotechnology has wrapped up the treatment phase for its pivotal Phase III insomnia trial involving 244 participants, setting the stage for an interim efficacy analysis expected in late June 2026.

Brightstar Resources is poised to hit a major milestone with a Final Investment Decision expected in June 2026, paving the way for first gold production by mid-2027 at its Goldfields Project in Western Australia.

Viking Mines has uncovered additional tungsten mineralisation in historical stockpiles near the Conquest mine at its Linka Project in Nevada, with ore sorting testwork underway and maiden drilling set for late June.

Comet Ridge has revised its acquisition deal for Santos’ stake in the Mahalo Gas Project, cutting upfront cash and extending deadlines to navigate new government gas reservation policy uncertainty.

Elanor Investors Group has obtained an ASX waiver allowing it to delay issuing stapled securities as part of its acquisition of Singapore-based Firmus Capital until July 10, 2026, due to pending regulatory approvals.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.

Hillgrove Resources has secured an option to earn an 80% stake in the Mutooroo Copper Project through a $10 million pre-feasibility study farm-in with Havilah Resources, aiming to leverage existing infrastructure to boost copper output.

Hillgrove Resources has secured the right to earn an 80% stake in the Mutooroo Copper Project through a farm-in deal with Havilah Resources, leveraging its Kanmantoo processing plant to potentially boost copper output with lower capital risk.

TruScreen Group Limited has kicked off a NZ$2.9 million capital raising combining a NZ$1 million placement and a NZ$1.94 million rights issue to fund its global expansion and regulatory compliance efforts. The company reported a 42% jump in product sales for FY2026 and is targeting major public health programs across 14 countries.